Unfortunately, both the PSMA-targeted and untargeted NP-based radioconjugates exhibited a similar marginal uptake in tumour tissue, indicating that intravenous administration of the radioconjugate is dubious due to the lack of effective delivery to the tumour tissue. Here, FOLH1 is linked to neoplasm.